Please complete the CAPTCHA to continue
@promethera.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Henrik Luessen is listed as Founder and Managing Director at Tytonis BV at eleva, a company with 17 employees, based in Amsterdam, North Holland, Netherlands. AeroLeads shows a work email signal at promethera.com and a matched LinkedIn profile for Henrik Luessen.
Henrik Luessen previously worked as Managing Director at Tytonis B.V. and Chief Business Officer (external) at Eleva. Henrik Luessen holds Ph.D., Pharmaceutics from Leiden University.
This section adds company-level context without repeating Henrik Luessen's masked contact details.
AeroLeads found 1 current-domain work email signal for Henrik Luessen. Compare company email patterns before reaching out.
Henrik Luessen is a Founder and Managing Director at Tytonis BV at eleva. He possess expertise in pharmaceutical industry, technology transfer, biotechnology, drug development, drug delivery and 45 more skills. He is proficient in English, German and Dutch.
Listed skills include Pharmaceutical Industry, Technology Transfer, Biotechnology, Drug Development, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Netherlands
Tytonis is a network organisation consisting of a multidisciplinary team of about 14 former pharma executives covering the areas of licensing, M&A, business/corporate development, communication strategy, patents, legal, project management, QA and regulatory.
Freiburg, Baden-Württemberg, Germany
Eleva is the inventor of their proprietary Bryotechnology-TM moss-based fermentation process allowing for human-like glycolisation pattern. Besides CDMO collaborations they offer two unique proprietary products developed to 2000 liter GMP scale, of which a) alpha galactosidase A has successfully completed a clinical phase 1b study, and b) recombinant human.
Wiesbaden, Germany
ICA Aesthetic Navigation GmbH is developing new personal assessment tools in the fields of aesthetic and medical dermatology.
Utrecht, Netherlands
Sapreme Technologies has invented and developed its unique endosomal escape platform to allow drugs safe and targeted delivery to the cytosolic compartment.
Tuebingen
Atriva Therapeutics is a new venture developing its proprietary MEK inhibitor platform to treat influenza infections. Currently the company seeks external funding to bring its compounds into the clinic. The charming aspect is that the compounds that have shown impressive results in preclinical studies are readily available through repurposing of existing.
Nijmegen, Netherlands
Xenikos is developing a new, life-saving therapy for corticosteroid resistant aGVHD (Orphan) based on a combination of two toxin (ricin-A) conjugated antibodies targeting either CD-3 or CD-7. The company is currently in ongoing clinical 2a studies with and reached a very positive interim result.
Beside my current position at Tytonis BV I was also appointed as CBO of Activaero on a part-time basis. It is a great company to be with and I am very much looking forward as part of the team to develop this company to become the world leader in inhalation therapy.
After being involved in the foundation process of InSCREENeX as a spin-out from the Helmholtz Center in Brunswig I joined as their CBO to promote their proprietary platforms Screenflex-TM and CI-Screen-TM. Our goal is to establish InSCREENeX as a market leader in advanced cell-based tox and compound screening technologies.
Responsible for commercial deveolpment of the company. Started when 16 employees present and left when 140 employees in the company. Activities include: Corporate strategy, licensing, M&A's, portfolio management, pharmaceutical development & drug delivery
Responsible for licensing of oral, skin care and environmental care products, co-responsible for Corporate Strategy, responsible for business development Asia
Other employees you can reach at elevabiologics.com. View company contacts for 17 employees →
Benjamin Fode
Colleague at ElevaFreiburg, Baden-Württemberg, Germany, Germany
View →
KB
Katharina Binder
Colleague at ElevaKirchzarten, Baden-Württemberg, Germany, Germany
View →
HN
Holger Niederkrüger
Colleague at ElevaGreater Freiburg Area, Germany
View →
HL
Heike Launhardt-Stemmer
Colleague at ElevaGreater Freiburg Area, Germany
View →
JS
Jonas Schweigel
Colleague at ElevaFreiburg, Baden-Württemberg, Germany, Germany
View →
JH
Judith H.
Colleague at ElevaGermany, Germany
View →
MD
Maja Delic
Colleague at ElevaGermany, Germany
View →
U(
Ulrike (Ulli) Ruzzoli
Colleague at ElevaTeningen, Baden-Württemberg, Germany, Germany
View →
MW
Manuela Wassermann-Heitzler
Colleague at ElevaGreater Freiburg Area, Germany
View →
MS
Marina Sarter-Schlüter
Colleague at ElevaGreater Freiburg Area, Germany
View →
Activities and Societies: APV (former Head of Group 'Pharmaceutical Biotechnology), EAPB (Governor of Executive Board), CRS, AAPSPh.D..
Activities and Societies: Academical Society Freia ReinbekPharmaceutical Sciences
Quick answers generated from the profile data available on this page.
Henrik Luessen works for eleva.
Henrik Luessen is listed as Founder and Managing Director at Tytonis BV at eleva.
AeroLeads has found 1 work email signal at @promethera.com for Henrik Luessen at eleva.
Henrik Luessen is based in Amsterdam, North Holland, Netherlands while working with eleva.
Henrik Luessen has worked for Tytonis B.V., Eleva, Ica Aesthetic Navigation Gmbh, Sapreme Technologies Bv, and Atriva Therapeutics Gmbh.
Henrik Luessen's colleagues at eleva include Benjamin Fode, Katharina Binder, Holger Niederkrüger, Heike Launhardt-Stemmer, and Jonas Schweigel.
You can use AeroLeads to view verified contact signals for Henrik Luessen at eleva, including work email, phone, and LinkedIn data when available.
Henrik Luessen holds Ph.D., Pharmaceutics from Leiden University.
Henrik Luessen is listed with skills including Pharmaceutical Industry, Technology Transfer, Biotechnology, Drug Development, Drug Delivery, Strategy, Biopharmaceuticals, and Clinical Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Henrik Luessen you were looking for.
